Company type | Public |
---|---|
ISIN | ES0171996012 |
Industry | Pharmaceuticals, chemicals |
Founded | 1940 |
Headquarters | Barcelona, Spain |
Key people | |
Products | Plasma derivatives, in vitro diagnostic products, non-biological products for laboratories and hospitals |
Revenue | €6.064 billion (2022) |
€805.7 million (2022) | |
€271.1 million (2022) | |
Total assets | €21.53 billion (2022) |
Total equity | €8.457 billion (2022) |
Number of employees | 26,314 (2022) |
Website | grifols |
Footnotes / references [1] [2] |
Grifols, S.A. (Catalan: [ˈɡɾifuls]) is a Spanish multinational pharmaceutical and chemical manufacturer. Principally a producer of blood plasma–based products, a field in which it is the European leader and largest worldwide,[3][4] the company also supplies devices, instruments, and reagents for clinical testing laboratories.